TrueFace Integrates Face and Thermal Screening Tech Into iryx Camera

TrueFace and iryx are teaming up to provide businesses with contactless temperature screening and access control capabilities. The joint solution combines iryx’s Indoor Mini thermal camera with TrueFace’s Elevated Body Temperature (EBT) solution and developer API.

The two companies are hoping that the new offering will appeal to public-facing organizations looking to prevent the spread of COVID-19. In that regard, TrueFace argues that its solution is superior to handheld temperature scanners, which place people in close proximity with one another and take more time than an automated system.

The Indoor Mini, on the other hand, is a plug-and-play camera with a built-in computer vision engine that can handle all of TrueFace’s processing requirements directly on-device. That includes the EBT solution and the facial recognition models available through the API.

Businesses that are only interested in temperature screening do not need to know any code, and will be up and running as soon as they plug in the camera. The system is able to locate the inner canthus of someone’s eye, and then scans the area to take that person’s temperature. The technology also provides liveness detection, since spoof props like photographs do not generate the same temperature readings that would be expected from a real human face.

Meanwhile, companies that are looking for a more robust access control solution can use the developer API to enable facial recognition and mask detection. The system provides access to a configuration server, and does not require any additional hardware thanks to the camera’s on-device processing capabilities.

TrueFace previously provided facial recognition technology for a digital community in Mexico, and has partnered with Modzy to create a solution that blends TrueFace’s facial recognition tech with Modzy’s pre-trained models. The iryx collaboration makes TrueFace the latest facial recognition provider to add temperature screening to its portfolio during the pandemic. 

–

January 22, 2021 – by Eric Weiss